Nachrichten zur Pfizer Inc. Aktie

Evotec: Mehrjährige Forschungskooperation mit Pfizer - Aktienanalyse

Kulmbach (www.aktiencheck.de) - Evotec-Aktienanalyse von "Der Aktionär": Marion Schlegel vom Anlegermagazin "Der Aktionär" nimmt die Aktie der Evotec SE (ISIN: DE0005664809,…

AKTIE IM FOKUS: Evotec mit neuem Erholungsversuch - Kooperation mit Pfizer

FRANKFURT (dpa-AFX Broker) - Die Aktien des Pharmawirkstoff-Forschers Evotec dürften sich am Mittwoch nach dem Vortagesrückschlag wieder dem Widerstand um…

Evotec: Kooperation mit Pfizer – das ist geplant

Nach der Korrektur am Dienstag geht es bei der Aktie von Evotec am Mittwochmorgen wieder nach oben. Das Papier profitiert…

Evotec: Kooperation mit Pfizer – das ist geplant

Nach der Korrektur am Dienstag geht es bei der Aktie von Evotec am Mittwochmorgen wieder nach oben. Das Papier profitiert…

JPMorgan belässt Pfizer auf Neutral - Ziel 30 Dollar

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Pfizer vor Zahlen zum zweiten Quartal mit einem…

EQS-News: Evotec SE: Evotec und Pfizer arbeiten zusammen, um Wirkstoffforschung in Frankreich voranzubringen

EQS-News: Evotec SE / Schlagwort(e): Sonstiges Evotec und Pfizer arbeiten zusammen, um Wirkstoffforschung in Frankreich voranzubringen 10.07.2024 / 07:30 CET/CEST…

EQS-News: Evotec und Pfizer arbeiten zusammen, um Wirkstoffforschung in Frankreich voranzubringen (deutsch)

Evotec und Pfizer arbeiten zusammen, um Wirkstoffforschung in Frankreich voranzubringen^EQS-News: Evotec SE / Schlagwort(e): SonstigesEvotec und Pfizer arbeiten zusammen, um…

Pfizer: Buy This Big Yielder On The Strong Pipeline

…

Pfizers chief scientist Mikael Dolsten to step down

…

Pfizers longtime science chief Mikael Dolsten to step down By Reuters

Pfizers longtime science chief Mikael Dolsten to step down…

Pfizers longtime science chief Mikael Dolsten to step down

Pfizer said on Tuesday its chief scientific officer Mikael Dolsten, a key figure behind the development of the companys COVID-19…

Pfizer: The Inflection Point Is Here

…

Want $1,000 in Dividend Income? Heres How Much You Have to Invest in Pfizer Stock

Dont ignore this drugmaker simply because its been unable to come up with a full replacement for Lipitor.…

Down 55%, Is Pfizer a Good Dividend Stock to Buy on the Dip?

…

Down 55%, Is Pfizer a Good Dividend Stock to Buy on the Dip?

Shares of the worlds largest drugmaker offer a dividend yield above 6% at recent prices.…

Down 55%, Is Pfizer a Good Dividend Stock to Buy on the Dip? @themotleyfool #stocks $PFE $ALNY

Shares of the worlds largest drugmaker offer a dividend yield above 6% at recent prices.…

Pfizer (PFE) Stock Slides as Market Rises: Facts to Know Before You Trade

Pfizer (PFE) concluded the recent trading session at $27.93, signifying a -0.43% move from its prior days close.…

Global Herpes Treatment Market Size To Worth USD 1.87 Billion By 2033 | CAGR Of 4.28%

The Global Herpes Treatment Market Size was Valued at USD 1.23 Billion in 2023 and the Worldwide Herpes Treatment Market…

Pfizer Hold

HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat die Einstufung für Pfizer mit einem Kursziel von 27 US-Dollar auf "Hold"…

Berenberg belässt Pfizer auf Hold - Ziel 27 Dollar

HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat die Einstufung für Pfizer mit einem Kursziel von 27 US-Dollar auf "Hold"…

GSK Secures mRNA Vaccines For Bird Flu, COVID And Seasonal Flu From Struggling Biotech CureVac

mRNA specialist CureVac, which struggled to compete with the likes of Pfizer, Moderna and BioNTech, said it will focus on…

Global Allergy Therapeutics Market Size To Exceed USD 42.5 Billion By 2033 | CAGR Of 6.29%

The Global Allergy Therapeutics Market Size was Valued at USD 23.1 Billion in 2023 and the Worldwide Allergy Therapeutics Market…

Pfizer (PFE) Stock Falls in a Year: Time to Buy, Sell or Hold?

Pfizer (PFE) expects its operational revenues to improve, driven by its in-line products like Vyndaqel, new launches like Abrysvo and…

Pharma Giants Claim Partial Wins in UK Case over Covid Vaccine Profits

Moderna Inc. scored a partial victory in its attempt to claim a share of billions of dollars in profits made…

1 Underwhelming Stat That May Have You Thinking Twice About Buying Pfizers Stock

Pfizers valuation looks attractive, but that doesnt mean the stock is a lock to outperform the broader market.…

1 Underwhelming Stat That May Have You Thinking Twice About Buying Pfizers Stock @themotleyfool #stocks $PFE

Pfizers valuation looks attractive, but that doesnt mean the stock is a lock to outperform the broader market.…

Pfizer: It Could Be A Bargain

…

Pfizer And Moderna Vaccines Not Linked To Birth Defects, Study Finds

The findings add to research showing vaccination during pregnancy is safe and effective amid growing evidence of severe risks from…

Pfizer Aktie: EU-Zulassung für Omikron-Impfstoff

Pfizer und BioNTech haben einen bedeutenden Meilenstein erreicht: Die Europäische Arzneimittelagentur hat ihrer angepassten monovalenten COVID-19-Vakzine für den Omikron-Stamm JN.1…

Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline

CNBC spoke with 11 current and former Pfizer employees, who asked to remain anonymous, about Pfizers dizzying climb, rapid decline…

Pfizer (PFE), BioNTechs Updated COVID-19 Jab Gets CHMP Nod

Pfizer (PFE) and BioNTechs Omicron JN.1-adapted COVID-19 vaccine gets the Committee for Medicinal Products for Human Uses positive opinion recommending…

BioNTech Aktie: Neuer Impfstoff Empfehlung Erhalten

Pfizer und BioNTech haben kürzlich eine wichtige Empfehlung für ihren neuesten COVID-19-Impfstoff von der europäischen Arzneimittelbehörde erhalten. Dieser auf Omikron…

Moderna: Erhöhtes Risiko für RSV-Schätzungen - Aktienanalyse

New York (www.aktiencheck.de) - Moderna-Aktienanalyse von Evercore ISI: Cory Kasimov, Analyst von Evercore ISI, bestätigt sein Rating und Kursziel für die…

GNW-Adhoc: Pfizer und BioNTech erhalten positive CHMP-Empfehlung für an Omikron JN.1 angepassten COVID-19-Impfstoff in der Europäischen Union

^* Der aktualisierte COVID-19-Impfstoff ist auf die Omikron JN.1-Sublinie von SARS-CoV-2 zugeschnitten und wird für Personen ab…

Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the European Union

NEW YORK and MAINZ, Germany, June 27, 2024 — Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”)…

GSK and Moderna slide on RSV vaccine CDC updates

GSK PLC (LSE:GSK, NYSE:GSK) shares fell 6% after US authorities recommended restrictions on doses of any respiratory syncytial virus (RSV) vaccine.…

CDC advisors narrow age recommendation for RSV shots in U.S.

Last year, GSK and Pfizer went head-to-head with rival RSV shots for all adults aged 60 and over, who could…

Moderna says its RSV shot is 50% effective after 18 months

In their clinical trials, GSKs RSV vaccine Arexvy was 78% effective in preventing severe RSV over a second year and…

Is Pfizers Pain Sarepta Therapeutics Gain? Dont Bet on It.

One companys negative results can increase scrutiny of anothers work.…

Pfizers Working on the Next Wegovy, but Can It Beat Novo Nordisk?

This is a matchup that the latecomer might not be able to win.…

Pfizer CEO reveals new weight loss drug mechanism in works

…

Global Contraceptive Drugs Market Size To Worth USD 40.08 Billion By 2033 | CAGR Of 8.02%

The Global Contraceptive Drugs Market Size was Valued at USD 18.53 Billion in 2023 and the Worldwide Contraceptive Drugs Market…

Pfizer (PFE) Stock Sinks As Market Gains: Heres Why

Pfizer (PFE) closed at $27.99 in the latest trading session, marking a -1.3% move from the prior day.…

Global Parkinson’s Disease Treatment Market Size To Worth USD 9.14 Billion By 2033 | CAGR Of 6.41%

The Global Parkinsons Disease Treatment Market Size was Valued at USD 4.91 Billion in 2023 and the Worldwide Parkinsons Disease…

UK Government Snubs GSK in Favor of Pfizer’s Rival RSV Shot

GSK Plc has lost out to Pfizer Inc. on a contract to supply millions of doses of its blockbuster RSV…

Pfizer: Seriously Undervalued At Peak Pessimism

…

Investing for the Next 12 Months? Buy These

If investors expect interest rates to hold until next year, they should consider dividend-yielding stocks like Altria (NYSE: MO), Bristol…

AKTIONÄR-Alt-Empfehlung Sarepta: "Homerun" – Aktie explodiert – Pfizer schaut in die Röhre

Die Biotech-Gesellschaft Sarepta Therapeutics fokussiert sich seit vielen Jahren auf die Entwicklung von gentherapeutischen Ansätzen zur Behandlung von Duchenne Muskeldystrophie…

The Zacks Analyst Blog Highlights Pfizer, Johnson & Johnson and Eli Lilly

Pfizer, Johnson & Johnson and Eli Lilly are part of the Zacks top Analyst Blog.…

Global Anal Fissure Treatment Market Size To Exceed USD 1986.1 Million By 2033 | CAGR Of 5.51%

The Global Anal Fissure Treatment Market Size was Valued at USD 1161.3 Million in 2023 and the Worldwide Anal Fissure…